Drug Efficacy Patient Outcomes Cohort Studies Case Reports Epidemiology Genetic Research Pediatric Studies Patient Data Cancer Research MRI Technology Dietary Interventions Microbiome Research Health Risks Drug Safety Cancer Treatment Imaging Techniques Danish Study Pediatric Health U.K. Biobank Fasting Research Toxicology Research Gout Research Visual Acuity Obesity Phase 2 Trials Genetic Factors Predictive Biomarkers Asthma Research Alzheimer's Disease Research Obesity and Kidney Disease Harvard University Heart Disease Studies Cardiovascular Research Participant Studies Dialysis Treatments Efficacy of Treatments Traumatic Brain Injury Pain Relief FDA Approval Research Findings Patient Recruitment Treatment Development Vitamin D Effects Rehabilitation Techniques Dietary Impact Fertility Clinics Lipoprotein Studies Collaboration in Research Disease Statistics Liver Damage Diagnosis Sleep Apnea Population Studies Aneurysm Research Vitiligo Fertility Treatments Pregnancy Complications Translational Medicine Magnesium and Hypertension Pediatric Neurology Therapeutic Applications Patient Care Hormone Therapy Body Composition Studies Immunotherapy Genetic Analysis Phase 3 Trials Real-World Evidence Urology Research Research Methodologies Liver Health Studies OASIS-3 Study Alternative Therapies Therapeutics Cross-Sectional Studies Associations Postpartum Health Neurodevelopmental Disorders Neonatal Care Standards GLP-1 Agonists Fertility Research Animal Models MRI Scans Inflammation Randomized Trials Therapeutic Strategies Food Allergy Treatments UK Biobank Chronic Fatigue Syndrome Patient Surveys Sports Medicine In Vitro Fertilization Sperm Function Studies Cognitive Assessment Biomarkers HRT Studies Diagnostic Accuracy Surgical Interventions Trial Results Pediatric Cardiology
The update follows overseas safety actions and arrives as Pfizer confronts lawsuits from more than 1,000 women over alleged failures to warn.